ProfileGDS5822 / ILMN_2668706
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 97% 97% 95% 97% 96% 97% 97% 96% 95% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11871.297
GSM1276600PDAC Late Ablation Control 21646.797
GSM1276601PDAC Late Ablation Control 31432.895
GSM1276602PDAC Late Ablation 11904.597
GSM1276603PDAC Late Ablation 21550.696
GSM1276604PDAC Late Ablation 32170.697
GSM1303940PDAC Late Ablation_anti-CTLA4 12239.997
GSM1303941PDAC Late Ablation_anti-CTLA4 21860.796
GSM1303942PDAC Late Ablation_anti-CTLA4 31309.495